Q-Pharma Consulting

Willebroek ·KBO/BCE: BE 0803.628.271

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	72.3%	51.1%	better than 68% of 1074 sector peers
Net result	€53k	€24k	better than 72% of 1074 sector peers
Equity	€91k	€51k	better than 65% of 1075 sector peers
Gross operating margin	€68k	€46k	better than 64% of 1074 sector peers
Total assets	€125k	€117k	better than 53% of 1075 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€125k
Fixed assets	21/28	€6k
Tangible fixed assets	22/27	€6k
Current assets	29/58	€119k
Amounts receivable within one year	40/41	€24k
Cash & bank	54/58	€94k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€125k
Equity	10/15	€91k
Contributions / capital	10/11	€1k
Reserves	13	€90k
Amounts payable	17/49	€35k
Amounts payable within one year	42/48	€35k
Trade debts payable within one year	44	€1k
Income statement
Gross operating margin	9900	€68k
Operating result	9901	€67k
Financial charges	65	€77
Result before taxes	9903	€67k
Income taxes	67/77	€14k
Net result for the period	9904	€53k
Result to be appropriated	9905	€53k

Summary